DNA Sequencing Market : Global Opportunity Analysis and Industry Forecast, 2017 – 2023

DNA sequencing is a molecular technique, which helps to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016 and is anticipated to reach $18,284 million by 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing has revolutionized molecular biology and genomics research. The knowledge of DNA sequences of genes and other parts of the genome of organisms has become essential for life-science research and is also in applied fields, such as forensics, cancer diagnostics, and others. Through this method, billions of DNA strands could be sequenced efficiently. DNA sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. They are utilized through varied interventions, such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.

Technological advancements in sequencing equipment, the surge in applications of DNA sequencing, and the increase in genome mapping programs drive the global DNA sequencing market. In addition, the rise in awareness pertaining to DNA sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitation related to DNA sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, the use of cloud computing as a potential data management service and the untapped emerging countries offer lucrative opportunities for the market players.

The DNA sequencing market is segmented based on product, application, technology, end user, and geography. Based on the product, it is categorized into consumable, instrument, and service. The consumables segment occupied a dominant share in 2016 and is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of DNA sequencing.

Based on the application, it is bifurcated into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. The biomarkers & cancer application was the highest revenue contributor in 2016, while the personalized medicine segment is anticipated to grow at the highest rate. The growth for this segment is due to the increase in investment in R&D globally and surge in awareness about DNA sequencing applications in precision medicine. Based on technology, the DNA sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, chain termination sequencing, and nanopore sequencing technologies. The sequencing by synthesis technology segment accounted for the highest share in 2016 and is estimated to continue this trend throughout the study period as this technology allows both short and long insert paired-end reads for high-resolution genome sequencing, structural variation detection, sequence assembly, and others.

Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the DNA sequencing market in 2016 and is expected to maintain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of DNA sequencing. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize DNA sequencing in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.

Product development is a key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global DNA sequencing market.

KEY PLAYERS PROFILED

Illumina, Inc.
Thermo Fisher Scientific, Inc.
Siemens AG
Pacific Biosciences of California, Inc.
ZS Genetics, Inc.
Beckman Coulter (Fullerton, CA)
454 Life Sciences Corporation (Roche Holding AG)
Agilent Technologies, Inc.
Abbott Laboratories.
LI-COR, Inc.

KEY MARKET BENEFITS

The study provides an in-depth analysis of the global DNA sequencing market and the current trends and future estimations to elucidate the imminent investment pockets.

The report presents a quantitative analysis of the market from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.

Extensive analysis of the market based on product assists to understand the trends in the industry.

Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry

Complete Report Details @ https://www.reportocean.com/industry-verticals/sample-request?report_id=27046

Note: The study base year and forecast period can be customized as per the request. Also, the table of contents is the defined scope of a published report. As per client requirement, cross-sectional analysis across all industries or specific geography or ‘country-based’ analysis can be provided as a part of customization

KEY MARKET SEGMENTS

By Product
Consumable
Instrument
Service

By Application
Diagnostics
Biomarkers and Cancer
Reproductive Health
Personalized Medicine
Forensics
Other Applications

By Technology
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real-Time Sequencing
Chain Termination Sequencing
Nanopore Sequencing

By End User 
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics

By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA

The other players in the value chain include (profiles not included in the report)
Eurofins Scientific
Gatc Biotech AG
Macrogen, Inc.
Oxford Nanopore Technologies, Ltd.
Bio-Rad Laboratories, Inc.
DNASTAR, Inc.
Biomatters Ltd.
New England Biolabs, Inc.
Myriad Genetics, Inc.

Continue…

Get more information, Ask for free sample copy: https://www.reportocean.com/industry-verticals/sample-request?report_id=27046

About us:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports. We will help you in finding the upcoming trends that will entitle you as a leader in the industry. We are here to work with you on your objective which will create an immense opportunity for your organization.

Contact us:
Company Name: Report Ocean
Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India
Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)
Contact Person: Sandeep Singh
URL: www.reportocean.com
Email: [email protected]

Posted by on Monday May 27 2019, 10:32 AM EDT. All trademarks acknowledged. Filed under Diagnostics, Healthcare, Medical Devices. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Latest News

Log in